[-] Show simple item record

dc.contributor.authorEpling, John W.
dc.date.issued2003-12eng
dc.description.abstractFluoxetine (Prozac) use may result in an average, short-term weight loss of up to 3.3 kg (7 lb, 4 oz) in obese patients, but the longterm effects and maintenance of weight loss after discontinuation of the drug have not been well studied. No evidence concerning other SSRIs was found. [Strength of recommendation: B, based on low-quality systematic reviews of randomized controlled trials (RCTs)]en_US
dc.identifier.citationAmerican Family Physician, 68(12) 2003: 2437-2438.en_US
dc.identifier.urihttp://hdl.handle.net/10355/11917
dc.publisherFamily Physicians Inquiry Networken_US
dc.relation.ispartofClinical Inquiries, 2003 (MU)en
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network
dc.subject.lcshSerotonin uptake inhibitorsen_US
dc.subject.lcshObesityen_US
dc.titleIs Fluoxetine an Effective Therapy for Weight Loss in Obese Patients?en_US
dc.typeArticleen_US


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record